Ratings by H.C. Wainwright (Douglas Tsao)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/9/2021 Radius Health RDUS Maintain Neutral
(N/A)
 
 
  Details
10/18/2021 Revance Therapeutic RVNC Maintain Buy
(N/A)
 
 
  Details
10/13/2021 Revance Therapeutic RVNC Maintain Buy
(N/A)
 
 
  Details
10/6/2021 Biohaven Pharmaceutical Holding BHVN Maintain Buy
(N/A)
 
 
  Details
8/3/2021 Outlook Therapeutics Incs. OTLK Maintain Buy
(N/A)
 
 
  Details
7/8/2021 Biohaven Pharmaceutical Holding BHVN Maintain Buy
(N/A)
 
 
  Details
6/21/2021 Protagonist Therapeutics PTGX Maintain Buy
(N/A)
 
 
  Details
5/25/2021 Rezolute RZLT New Coverage Buy
(N/A)
6.45
(5.27)
-18.29% Details
5/10/2021 Immunovant IMVT Maintain Buy
(N/A)
 
 
  Details
5/10/2021 argenx SE ARGX Upgrade Buy
(Neutral)
263.70
(282.82)
7.25% Details
5/6/2021 Chiasma CHMA Maintain Buy
(N/A)
 
 
  Details
4/29/2021 Alkermes ALKS Maintain Buy
(N/A)
 
 
  Details
3/23/2021 Protagonist Therapeutics PTGX Maintain Buy
(N/A)
 
 
  Details
3/11/2021 Protagonist Therapeutics PTGX Maintain Buy
(N/A)
 
 
  Details
3/2/2021 Chiasma CHMA Maintain Buy
(N/A)
 
 
  Details
2/22/2021 Evolus EOLS Maintain Buy
(N/A)
 
 
  Details
2/4/2021 GW Pharma GWPH Downgrade Buy
(Buy)
211.37
(218.96)
3.59% Details
12/18/2020 Dare Bioscience DARE New Coverage Buy
(N/A)
1.13
(1.80)
59.29% Details
12/15/2020 GW Pharma GWPH New Coverage Buy
(N/A)
121.22
(218.96)
80.63% Details
11/6/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
10/13/2020 Cabaletta Bio Inc. CABA New Coverage Buy
(N/A)
11.28
(11.63)
3.1% Details
10/2/2020 AMAG Pharmaceuticals AMAG Downgrade Neutral
(Buy)
13.65
(13.75)
0.73% Details
8/27/2020 Outlook Therapeutics Incs. OTLK Maintain Buy
(N/A)
 
 
  Details
8/26/2020 Immunovant IMVT Maintain Buy
(N/A)
 
 
  Details
8/25/2020 Momenta Pharmaceuticals MNTA Downgrade Neutral
(Buy)
52.15
(52.48)
0.63% Details
8/12/2020 Chiasma CHMA Maintain Buy
(N/A)
 
 
  Details
8/6/2020 AMAG Pharmaceuticals AMAG Maintain Buy
(N/A)
 
 
  Details
8/4/2020 GW Pharma GWPH Maintain Buy
(N/A)
 
 
  Details
7/29/2020 Momenta Pharmaceuticals MNTA Maintain Buy
(N/A)
 
 
  Details
7/29/2020 Immunovant IMVT New Coverage Buy
(N/A)
23.32
(7.66)
-67.15% Details
7/29/2020 argenx SE ARGX New Coverage Neutral
(N/A)
253.23
(282.82)
11.69% Details
7/1/2020 Marinus Pharmaceuticals MRNS Maintain Buy
(N/A)
 
 
  Details
6/29/2020 Chiasma CHMA Maintain Buy
(N/A)
 
 
  Details
6/16/2020 Momenta Pharmaceuticals MNTA Maintain Buy
(N/A)
 
 
  Details
6/8/2020 Minerva Neurosciences NERV Maintain Buy
(N/A)
 
 
  Details
6/8/2020 Minerva Neurosciences NERV Maintain Buy
(Buy)
 
 
  Details
5/27/2020 Outlook Therapeutics Incs. OTLK Maintain Buy
(Buy)
 
 
  Details
5/18/2020 Protagonist Therapeutics PTGX Maintain Buy
(N/A)
 
 
  Details
5/13/2020 scPharmaceuticals SCPH Maintain Buy
(N/A)
 
 
  Details
5/12/2020 AMAG Pharmaceuticals AMAG Maintain Buy
(N/A)
 
 
  Details
4/17/2020 AMAG Pharmaceuticals AMAG Maintain Buy
(N/A)
 
 
  Details
2/27/2020 GW Pharma GWPH Maintain Buy
(N/A)
 
 
  Details
2/26/2020 Revance Therapeutic RVNC Maintain Buy
(N/A)
 
 
  Details
2/26/2020 Evolus EOLS Maintain Buy
(N/A)
 
 
  Details
2/25/2020 Theravance Biopharma TBPH Maintain Buy
(N/A)
 
 
  Details
1/23/2020 Dermira DERM Downgrade Neutral
(Buy)
18.83
(8.40)
-55.39% Details
10/30/2019 AMAG Pharmaceuticals AMAG Maintain Buy
(Buy)
 
 
  Details
10/30/2019 Sage Therapeutics SAGE New Coverage Neutral
(N/A)
140.16
(38.35)
-72.64% Details
10/30/2019 GW Pharma GWPH New Coverage Buy
(N/A)
134.06
(218.96)
63.33% Details
10/15/2019 scPharmaceuticals SCPH New Coverage Buy
(N/A)
5.90
(4.60)
-22.03% Details
9/25/2019 Momenta Pharmaceuticals MNTA New Coverage Buy
(N/A)
13.10
(52.48)
300.61% Details
9/4/2019 Trevena TRVN Maintain Buy
(Buy)
 
 
  Details
7/18/2019 Outlook Therapeutics Incs. OTLK New Coverage Buy
(N/A)
2.02
(1.46)
-27.72% Details
7/8/2019 Protagonist Therapeutics PTGX New Coverage Buy
(N/A)
12.50
(32.06)
156.48% Details
5/31/2019 Trevena TRVN New Coverage Buy
(N/A)
1.19
(0.68)
-42.86% Details
3/27/2019 Dermira DERM Maintain Buy
(N/A)
 
 
  Details
2/14/2019 Radius Health RDUS New Coverage Neutral
(N/A)
19.60
(16.57)
-15.46% Details
2/14/2019 Crinetics CRNX New Coverage Buy
(N/A)
24.86
(25.04)
0.72% Details
2/14/2019 Revance Therapeutic RVNC New Coverage Buy
(N/A)
17.86
(13.81)
-22.68% Details
2/14/2019 Evolus EOLS New Coverage Buy
(N/A)
26.56
(5.42)
-79.59% Details
2/14/2019 Chiasma CHMA New Coverage Buy
(N/A)
3.53
(3.79)
7.37% Details